LEUKEMIA & RELATED MALIGNANCIESChronic Lymphocytic LeukemiaPoster: CLL-140 Booster and BTKi Interruption Improve Response to SARS-CoV-2 Vaccine in Patients With CLL
Chronic Lymphocytic Leukemia
Cited by (0)
Copyright © 2022 Elsevier Inc. All rights reserved.